Neuropsychological and neuroimaging phenotype induced by a CAMTA1 mutation

Brain Dev. 2014 Sep;36(8):711-5. doi: 10.1016/j.braindev.2013.09.008. Epub 2013 Oct 18.

Abstract

Background/aims: CAMTA1 mutations have recently been reported in families with intellectual disability and/or non-progressive congenital ataxias. The objective of this study was to describe the neuropsychological and neuroimaging phenotype of CAMTA1 mutation.

Methods: We performed neuropsychological examinations, MRI and FDG-PET imaging in three patients with autosomal dominant mild intellectual disabilities and ataxia induced by a CAMTA1 intragenic deletion at 1p36.31p36.23.

Results: Neuropsychological tests showed similar findings in two patients, with low information processing speed, slow memory consolidation, phonological disorders, working memory deficits, but mainly preserved executive function. Bilateral parietal and medial temporal abnormalities were found on brain MRI. Diffuse parieto-occipital and local left temporo-parietal decrease of FDG uptake was observed on PET images.

Conclusion: These results suggest that CAMTA1 mutation may induce an unusual neuropsychological profile and parieto-temporal developmental abnormalities. We recommend screening for CAMTA1 mutations in patients with autosomal dominant mild intellectual disability presenting with similar a phenotype.

Keywords: CAMTA1; Genetic; Intellectual disability; MRI; Neuropsychology; PET; Parietal cortex.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Ataxia / genetics*
  • Ataxia / pathology*
  • Brain / pathology*
  • Calcium-Binding Proteins / genetics*
  • Female
  • Fluorodeoxyglucose F18
  • Gene Deletion*
  • Humans
  • Intellectual Disability / genetics*
  • Intellectual Disability / pathology*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Phenotype
  • Positron-Emission Tomography
  • Trans-Activators / genetics*

Substances

  • CAMTA1 protein, human
  • Calcium-Binding Proteins
  • Trans-Activators
  • Fluorodeoxyglucose F18